Jan 10, 2022 | Adverse selection, Cost Savings, Savings, Spousal limitations
Because you don’t want to be on the negative end of adverse selection. About 1 in 5 employers currently use spousal limitations, ranging from surcharges and carve-outs to exclusion of all spouses from the plan. Spousal limitations can reduce the chances of...
Jan 7, 2022 | Brand Name Drugs, Cost Savings, Generic Drugs, MedBen Rx, Prescription, Rx Costs, Savings, Specialty Care
GoodRx is currently compiling a list of drugs that will cost consumers more in 2022. By January 17, 669 drugs will have experienced price increases, with an average increase of 5.0%. All but 11 on the list are brand-name medications. The list includes such well-known...
Dec 14, 2021 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Social Media
MedBen Rx already provides pharmacy solutions that save… but in the spirit of the season, we’d like to give you something extra! By following us on LinkedIn and downloading the MedBen Rx brochure by Monday, December 20, 2021 you will be automatically...
Dec 13, 2021 | Administrative Services Only, Alternative Reimbursement Strategies, Claims Management, Cost Savings, Forensic claims analysis, MedBen Rx, MedBen WellLiving, Savings, Self-funding
Because your health plan belongs to you. A plan should be built around your goals, not the insurance carrier’s. The one-size-fits-all approach used by Administrative Services Only (“ASO”) organizations just won’t cut it if you want the best...
Nov 30, 2021 | Case Studies, Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings
In their first year with MedBen Rx, a regional health system lowered costs by $4.6 million through pharmacy savings and added revenue. This includes a 30% reduction in employee pharmacy plan spend. The health system had previously entered into three-year agreement...
Nov 26, 2021 | Cancer, Cost Savings, MedBen WellLiving, Preventive Care, Savings
Care for the 15 most prevalent types of cancer in the United States cost approximately $156.2 billion in 2018, a new study finds. Drugs for breast, lung, lymphoma and colorectal cancers incurred the highest costs. “Cancer is … actually overtaking heart disease as the...
